Back
ARK Innovation ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison
Buy
97
ARKK
ARK Innovation ETF
Last Price:
$62.77
Seasonality Move:
6.36%
Sell
47
APLS
Apellis Pharmaceuticals
Last Price:
$18.91
Seasonality Move:
2.19%
Buy
97
ARK Innovation ETF (ARKK)
is a Buy
Is ARK Innovation ETF a Buy, Sell or Hold?
-
The current ARK Innovation ETF [ARKK] share price is $63.53. The Score for ARKK is 97, which is 94% above its historic median score of 50, and infers lower risk than normal.
-
ARKK is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
47
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals [APLS] share price is $19.27. The Score for APLS is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARKK Stock Price Chart
What is ARK Innovation ETF's stock price today?
-
The ARK Innovation ETF share price today is $63.53Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARKK is experiencing slight selling pressure.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $19.27The current trend is relatively stagnant and APLS is experiencing selling pressure, which indicates risk of future bearish movement.
ARKK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.51 | Buy |
Relative Strength Index (14 RSI): | 71.29 | Buy |
Chaikin Money Flow: | -2710884 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (53.89 - 60.31) | Buy |
Bollinger Bands (100): | (48.33 - 61.17) | Buy |
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.18 | Buy |
Relative Strength Index (14 RSI): | 55.5 | Buy |
Chaikin Money Flow: | -2395893 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.99 - 18.87) | Buy |
Bollinger Bands (100): | (18.16 - 27.5) | Sell |
ARKK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 59.93 | Buy |
20-day SMA: | 58.15 | Buy |
50-day SMA: | 52.2 | Buy |
200-day SMA: | 53.12 | Buy |
8-day EMA: | 60.64 | Buy |
20-day EMA: | 58.03 | Buy |
50-day EMA: | 55.13 | Buy |
200-day EMA: | 52.81 | Buy |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.14 | Buy |
20-day SMA: | 18.02 | Buy |
50-day SMA: | 18.61 | Buy |
200-day SMA: | 27.46 | Sell |
8-day EMA: | 18.98 | Buy |
20-day EMA: | 18.52 | Buy |
50-day EMA: | 19.51 | Sell |
200-day EMA: | 27.51 | Sell |
ARK Innovation ETF Earnings Growth & ARKK Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.14 per share, and an increase next year of $1.12 per share.
ARK Innovation ETF Technical Analysis
May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apellis Pharmaceuticals Technical Analysis
May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |